Pfizer (PFE) Surges 8%, Merck (MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.08 -1.19%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 7.1%
EPS Growth %: -12.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 7.1%
EPS Growth %: -12.8%
Join SI Premium – FREE
Pfizer (NYSE: PFE) Surges 8%, Merck (NYSE: MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DLH Holdings names new CEO and CFO as Parker retires after 16 years
- Supreme Court to hear Apple appeal in Epic antitrust case
- REalloys CFO resigns; Craig Cunningham appointed as replacement
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
